Opportunity at National Institute of Standards and Technology (NIST)
Hydrogen/Deuterium Exchange Mass Spectrometry of Proteins and Biosimilar Drugs
Material Measurement Laboratory, Biomolecular Measurement Division
Please note: This Agency only participates in the February and August reviews.
|Hudgens, Jeffrey Warren
||240-314-6485 (IBBR/NIST, Rockville)
This research develops and applies hydrogen/deuterium exchange mass spectrometry (HDX-MS) for determining the dynamic physical-chemical properties of proteins, glycoproteins, peptides, peptide-metal complexes, receptors, and biocatalysts. Topics of particular interest include the effects of post-translational modifications (PTMs) on protein dynamic structure and protein-ligand interactions, structure-function relationships between glycan structure and glycoprotein folding, and comparability measurements among innovator drugs and biosimilar drug candidates. This research is conducted at the nearby NIST & UMD joint Institute for Bioscience & Biotechnology Research. The well-equipped laboratory includes a fully automated HDX Orbitrap tandem mass spectrometer with ETD capability, a MALDI-TOF/TOF, a wide variety of analytical and preparation chromatographs, and numerous optical/NMR spectroscopic instruments.
Bioactivity; Biocatalyst; Biomolecule; Biosimilar; Cell signaling; Conformation; ECD; Electron capture dissociation; Electron transfer dissociation; ETD; Glycan; Glycoeptitope; Glycoprotein; Glycosylation; H/D exchange; Hydrogen-deuterium exchange; HDX-MS; HXMS; Ion fragmentation; Mass spectra; Mass spectrometry; Membrane protein; Myristoylated protein; Myristoylation; Peptide; Protein; Structure function; Tandem mass spectrometry; Transmembrane protein;
Open to U.S. citizens
Open to Postdoctoral applicants